Regulation of synthetic biology : bioBricks, biopunks and bioentrepreneurs /
This book explores the interplay between regulation and emerging technologies in the context of synthetic biology, a developing field that promises great benefits, and has already yielded fuels and medicines made with designer micro-organisms. For all its promise, however, it also poses various risk...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Typ dokumentu: | Kniha |
| Jazyk: | Angličtina |
| Vydáno: |
Cheltenham :
Edward Elgar Publishing,
2018
|
| Edice: | Elgar studies in law and regulation
|
| Témata: | |
| On-line přístup: | Elektronická verze přístupná pouze pro studenty a pracovníky MU |
| Příbuzné jednotky: | Tištěná verze::
Regulation of synthetic biology : bioBricks, biopunks and bioentrepreneurs |
| LEADER | 06898cam a22006497i 4500 | ||
|---|---|---|---|
| 001 | MUB03000007975 | ||
| 003 | CZ BrMU | ||
| 005 | 20211012102357.0 | ||
| 008 | 190122s2018 xxk|||||o|||||||||||eng d | ||
| STA | |a EIZ |b 515 |c ELGARONLINE trvale nakupy |d 2019-01-21 | ||
| 020 | |a 978-1-78536-944-5 |q (e-book) | ||
| 035 | |a (UtOrBLW)eep9781785369445 | ||
| 040 | |a DLC |b cze |e rda |c DLC |d UtOrBLW |d BOD010 | ||
| 072 | 7 | |a 60 |x Biotechnologie. Genetické inženýrství |2 Konspekt |9 2 | |
| 080 | |a 602.66 |2 MRF | ||
| 080 | |a 504 |2 MRF | ||
| 080 | |a 608.3 |2 MRF | ||
| 080 | |a (0.034.2:08) |2 MRF | ||
| 100 | 1 | |a McLennan, Alison |7 mub2013744144 |4 aut | |
| 245 | 1 | 0 | |a Regulation of synthetic biology : |b bioBricks, biopunks and bioentrepreneurs / |c Alison McLennan |
| 264 | 1 | |a Cheltenham : |b Edward Elgar Publishing, |c 2018 | |
| 300 | |a 1 online zdroj (ix, 407 stran) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a počítač |b c |2 rdamedia | ||
| 338 | |a online zdroj |b cr |2 rdacarrier | ||
| 490 | 1 | |a Elgar studies in law and regulation | |
| 504 | |a Obsahuje bibliografii, bibliografické odkazy a rejstřík | ||
| 505 | 0 | |a Part I: The new world of synthetic biology: possibilities, challenges and debates -- 1. Introduction -- 2. Making biology easy to engineer: the science of synthetic biology, the emergence of the field and its major applications -- 3. Science meets politics, activists and governance: evaluating key positions in synthetic biology debates -- 4. New directions : the United States presidential commission's investigation of synthetic biology's risks, benefits and oversight -- Part II: Regulating for the risks -- 5. Environmental risk: uncertainty, precaution, prudent vigilance and adaptation -- 6. Synthetic biology, biosafety and 'biopunks' -- 7. Biosecurity: potential for deliberate misuse of synthetic biology -- Part III Regulating for the benefits -- 8. How will patents affect synthetic biology? -- 10. Conclusion and future directions -- Bibliography -- Index. | |
| 520 | 9 | |a This book explores the interplay between regulation and emerging technologies in the context of synthetic biology, a developing field that promises great benefits, and has already yielded fuels and medicines made with designer micro-organisms. For all its promise, however, it also poses various risks. Investigating the distinctiveness of synthetic biology and the regulatory issues that arise, Alison McLennan questions whether synthetic biology can be regulated within existing structures or whether new mechanisms are needed. Adopting an interdisciplinary approach, McLennan draws on diverse areas of law, the science of synthetic biology and the history and sociology of science. She concludes that synthetic biology presents novel regulatory challenges relating to environmental risk, biosafety, biosecurity and intellectual property.- |9 eng | |
| 520 | 9 | |a These challenges arise from the uniqueness of the science, the nature of its communities of scientists (including citizen scientists or 'biobunks') and the uncertainty surrounding possible hazards. Some scientists see intellectual property protection as a way to push innovation forward (bioentrepreneurs), while others openly share synthetic biology tools such as BioBricks. By understanding the range of regulatory challenges, the book make a case for enhanced regulation that protects us from synthetic biology's risks, whilst capturing its potential to improve our world. Regulation of Synthetic Biology will be essential reading for academics and students in the social sciences and law, as well as for scientists working in synthetic biology, and policymakers in innovation, science and the regulation of these fields.- |9 eng | |
| 520 | 9 | |a This book explores the interplay between regulation and emerging technologies in the context of synthetic biology, a developing field that promises great benefits, and has already yielded fuels and medicines made with designer micro-organisms. For all its promise, however, it also poses various risks. Investigating the distinctiveness of synthetic biology and the regulatory issues that arise, Alison McLennan questions whether synthetic biology can be regulated within existing structures or whether new mechanisms are needed. Adopting an interdisciplinary approach, McLennan draws on diverse areas of law, the science of synthetic biology and the history and sociology of science. She concludes that synthetic biology presents novel regulatory challenges relating to environmental risk, biosafety, biosecurity and intellectual property.- |9 eng | |
| 520 | 9 | |a These challenges arise from the uniqueness of the science, the nature of its communities of scientists (including citizen scientists or 'biobunks') and the uncertainty surrounding possible hazards. Some scientists see intellectual property protection as a way to push innovation forward (bioentrepreneurs), while others openly share synthetic biology tools such as BioBricks. By understanding the range of regulatory challenges, the book make a case for enhanced regulation that protects us from synthetic biology's risks, whilst capturing its potential to improve our world. Regulation of Synthetic Biology will be essential reading for academics and students in the social sciences and law, as well as for scientists working in synthetic biology, and policymakers in innovation, science and the regulation of these fields. |9 eng | |
| 533 | |a Elektronická reprodukce. |n Přístup pouze pro oprávněné uživatele | ||
| 650 | 0 | 7 | |a syntetická biologie |7 ph613275 |2 czenas |
| 650 | 0 | 7 | |a environmentální rizika |7 ph119962 |2 czenas |
| 650 | 0 | 7 | |a biologická bezpečnost |7 ph221957 |2 czenas |
| 650 | 0 | 9 | |a synthetic biology |2 eczenas |
| 650 | 0 | 9 | |a environmental risk |2 eczenas |
| 650 | 0 | 9 | |a biological safety |2 eczenas |
| 655 | 7 | |a e-knihy online |2 CZ-BrMU | |
| 655 | 9 | |a e-books online |2 eCZ-BrMU | |
| 710 | 2 | |a Edward Elgar Publishing |7 kn20071203001 |4 pbl | |
| 776 | 0 | 8 | |i Tištěná verze: |a McLennan, Alison. |t Regulation of synthetic biology : bioBricks, biopunks and bioentrepreneurs |z 978-1-78536-943-8 |
| 830 | 0 | |a Elgar studies in law and regulation | |
| 856 | 4 | 1 | |z Elektronická verze přístupná pouze pro studenty a pracovníky MU |u https://www.elgaronline.com/view/9781785369438/9781785369438.xml |
| CAT | |c 20190122 |l MUB03 |h 1821 | ||
| CAT | |c 20190304 |l MUB03 |h 1343 | ||
| CAT | |c 20190304 |l MUB03 |h 1403 | ||
| CAT | |c 20200810 |l MUB03 |h 1635 | ||
| CAT | |c 20210421 |l MUB03 |h 2124 | ||
| CAT | |c 20210421 |l MUB03 |h 2208 | ||
| CAT | |a HONIGOVA |b 02 |c 20210921 |l MUB03 |h 0916 | ||
| CAT | |a HONIGOVA |b 02 |c 20211012 |l MUB03 |h 1023 | ||
| 995 | |a eBook | ||
| 994 | - | 1 | |l MUB03 |l MUB03 |m EBOOK |1 PRAF |a Právnická fakulta |2 EBLAW |b e-knihy (trvalý nákup) |3 EBOOK-319 |5 3129L00319 |8 20190304 |f 83 |f Dálkově přístupná |r 20190304 |
| AVA | |a LAW50 |b PRAF |c e-knihy (trvalý nákup) |d EBOOK-319 |e available |t K dispozici |f 1 |g 0 |h N |i 0 |j EBLAW | ||